All In Biotech

Drug Trial Radar · NCT05176691

HMPL-760 Safety and Tolerability Study in Patients With Previously Treated CLL/SLL or NHL

A Multicenter, Open-label, Phase 1 Study Evaluating the Safety and Tolerability of HMPL-760 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Other Non-Hodgkin Lymphoma (NHL)

Last checked: Nov 19, 2026Latest source record: Feb 21, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Feb 15, 2022

Primary completion

Nov 16, 2022

Study completion Nov 16, 2022

Sponsor

Lead sponsor
HutchmedIndustry
Sponsor type
Industry
First posted
Jan 4, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

An open label single-arm clinical trial to evaluate the safety, tolerability, PK, PD, and preliminary efficacy of HMPL-760 in patients with previously treated CLL/SLL or NHL

Conditions

  • CLL/SLL
  • NHL
  • MCL
  • MZL
  • Lymphoplasmacytic Lymphoma
  • Waldenstrom Macroglobulinemia
  • Follicular Lymphoma
  • DLBCL
  • Richter Syndrome

Interventions

  • HMPL-760Drug

    Administered orally QD for 28-day cycles

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of DLTsTime frame: Up to 28 days after first dose of study drug
  2. Incidence of AEs/SAEsTime frame: From 1st dose to within 30 days of last dose
  3. MTDTime frame: From 1st dose to within 30 days of last dose
  4. RP2DTime frame: From 1st dose to within 30 days of last dose

Locations

36 sites in 7 countries. Site status is shown where the registry gives one.

  • Innovative Clinical Research

    Anaheim, California

  • Emory University Hospital

    Atlanta, Georgia

  • Tulane Cancer Center

    New Orleans, Louisiana

  • Johns Hopkins Clinical Research Center

    Baltimore, Maryland

  • AMR Kansas City, Formerly Center for Pharmaceutical Research, an AMR company

    Kansas City, Missouri

  • Center For Advanced Medicine

    St Louis, Missouri

  • Summit Medical Group

    Florham Park, New Jersey

  • New York University Langone Med Center. Lab

    New York, New York

  • Clinical Research Alliance

    Westbury, New York

  • Renovatio Clinical

    El Paso, Texas

  • Oncology Consultants, P.A.

    Houston, Texas

  • Renovatio Clinical

    The Woodlands, Texas

  • Royal Adelaide Hospital

    Adelaide, South Australia, Australia

  • Centre Antoine Lacassagne

    Nice, Alpes Maritimes, France

  • Hôpital Saint-Antoine

    Paris, Paris, France

  • Groupe Hospitalier Pitie-Salpetriere

    Paris, Paris, France

  • Institut Gustave Roussy

    Villejuif, Val De Marne, France

  • CHU Poitiers - Hôpital la Milétrie

    Poitiers, Vienne, France

  • Hadassah University Hospital - Ein Kerem

    Jerusalem, Israel

  • Rabin Medical Center-Beilinson Campus

    Petah Tikva, Israel

  • Chaim Sheba Medical Center

    Ramat Gan, Israel

  • Tel Aviv Sourasky Medical Center

    Tel Aviv, Israel

  • Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi IRCCS

    Bologna, Italy

  • Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico

    Milan, Italy

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    Lazio, Roma, Italy

  • Fondazione del Piemonte per l'Oncologia IRCC Candiolo

    Candiolo, Torino, Italy

  • Pratia Onkologia Katowice

    Katowice, Poland

  • Wojewodzki Szpital Specjalistyczny w Legnicy

    Legnica, Poland

  • Centrum Medyczne Pratia Poznan

    Skórzewo, Poland

  • MICS Centrum Medyczne Torun

    Torun, Poland

  • Hospital del Mar

    Barcelona, Spain

  • MD Anderson Cancer Centre

    Madrid, Spain

  • Hospital Universitario Ramon y Cajal

    Madrid, Spain

  • ICO l'Hospitalet - Hospital Duran i Reynals

    L'Hospitalet de Llobregat, Barcelona, Spain

  • Hospital Universitario Quironsalud Madrid

    Pozuelo de Alarcón, Madrid, Spain

  • Hospital Universitario Virgen del Rocio

    Seville, Sevilla, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.